InsiderTrades

Form 4 for TMDX TransMedics Group, Inc.

Accepted 2022-12-13 00:00:00 ET · period of report 2022-09-02 · accession 0000899243-22-038318 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-12-13 2022-12-09 TMDX Provost Miriam VP, Gbl Regulatory Affairs S - Sale+OE $59.00 -3,613 13.6K -21% -$213.2K
DM 2022-12-13 2022-09-02+ TMDX Provost Miriam VP, Gbl Regulatory Affairs M - OptEx $23.28 +7,726 14.1K +121% +$179.9K
DM 2022-12-13 2022-09-02+ TMDX Provost Miriam VP, Gbl Regulatory Affairs M - OptEx $0.00 -7,726 8,226 -48% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-09 S D 3,046 $59.00 12,969 D — —
2 Common Common Stock 2022-12-09 M A 3,977 $38.46 16,015 D — —
3 Common Common Stock 2022-09-02 M A 2,600 $3.22 12,038 D — —
4 Common Common Stock 2022-12-09 S D 567 $59.00 13,551 D — —
5 Common Common Stock 2022-12-09 M A 1,149 $16.14 14,118 D — —
6 Derivative Stock Option (Right to Buy) 2022-09-02 M D 2,600 $0.00 18,281 D $3.22 · — to 2028-04-05 2,600 Common Stock (F2) The option is fully vested.
7 Derivative Stock Option (Right to Buy) 2022-12-09 M D 3,977 $0.00 21,023 D $38.46 · — to 2031-02-24 3,977 Common Stock (F3) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
8 Derivative Stock Option (Right to Buy) 2022-12-09 M D 1,149 $0.00 8,226 D $16.14 · — to 2030-02-27 1,149 Common Stock (F4) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.